Waters Corporation

370 articles about Waters Corporation

• 

  The Top 12 Biopharma Companies Hiring Now

  11/1/2023

  October saw a surge of life science job activity with job applications up 65% from last year as well as a number of a significant layoff announcements.

• Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits

  10/19/2023

  Waters Corporation announces the launch of OligoWorks™ SPE Kits and components to improve sample preparation for LC-MS-based bioanalytical quantitation of therapeutic oligonucleotides.

• Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies

  9/20/2023

  Waters Corporation introduces the DynaPro™ ZetaStar™ instrument from its Wyatt Technology™ portfolio for nanoparticle analysis.

• Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

  9/12/2023

  Waters Corporation announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis.

• Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023

  8/30/2023

  Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference in London on Wednesday, September 13th, 2023 at 8:20AM Eastern Time

• Waters Corporation and Princeton University Announce Multi-Year Research Collaboration

  6/26/2023

  Waters and Princeton University signed a multi-year agreement to take on real-world challenges in biologics and materials research.

• Waters Boosts Resolution and Triples Scan Speed of SELECT SERIES MRT for Metabolomics and MS Imaging

  6/5/2023

  Waters Corporation announced new updates to its SELECT SERIES™ MRT System that increases its specificity and utility for UPLC-MS/MS metabolomics and drug discovery applications and for mass spectrometry imaging experiments.

• Waters Takes Targeted, Quantitative Imaging to the Next Level with New DESI Source for the Xevo TQ Absolute System

  6/5/2023

  Waters Corporation launched the industry's first targeted imaging mass spectrometer based on its Xevo™ TQ Absolute tandem quadrupole mass spectrometer, the most sensitive and compact mass spectrometer in its class.

• Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing

  6/5/2023

  Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics.

• Waters Corporation to Present at the Jefferies 2023 Healthcare Conference

  5/23/2023

  Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th, 2023 at 9:30AM Eastern Time.

• Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology

  5/16/2023

  Waters™ Corporation announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services.

• Waters Corporation (NYSE: WAT) Reports First Quarter 2023 Financial Results

  5/9/2023

  Waters Corporation announced its financial results for the first quarter of 2023.

• Waters Corporation Schedules First Quarter 2023 Earnings Conference Call

  4/17/2023

  Waters Corporation (NYSE:WAT) will hold its Q1 2023 financial results conference call live on Tuesday, May 9th 2023 at 8:00 a.m. Eastern Time.

• Waters Launches its Most Sensitive and Compact Clinical IVD System with Xevo TQ Absolute IVD Mass Spectrometer

  4/4/2023

  Waters Corporation unveiled its next generation Xevo TQ Absolute IVD mass spectrometer, expanding its family of MassTrak IVD LC-MS/MS Systems for clinical diagnostic applications.

• Waters Corporation Appoints Richard Fearon to Board of Directors

  3/28/2023

  Waters™ Corporation (NYSE:WAT) today announced the appointment of Richard Fearon to its Board of Directors, effective March 27, 2023.

• Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors

  3/20/2023

  Waters Corporation introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use.

• Waters Corporation Presentation at the Cowen 43rd Annual Health Care Conference to be Webcast Live

  2/23/2023

  Waters Corporation Udit Batra Ph.D., Waters’ President and Chief Executive Officer, will participate in a fireside chat at the Cowen Healthcare Conference on Monday, March 6th, 2023 at 9:50AM Eastern Time.

• Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2022 Financial Results

  2/15/2023

  Waters Corporation announced its financial results for the fourth quarter and full-year 2022.

• Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader

  2/15/2023

  Waters Corporation (NYSE:WAT) today announced it has entered into an agreement to acquire Wyatt Technology, a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories, and services, for $1.36 billion in cash, subject to certain adjustments.

• Waters Corporation Schedules Fourth Quarter 2022 Earnings Conference Call

  1/18/2023

  Waters Corporation will hold its Q4 2022 financial results conference call live on Wednesday, February 15th 2023 at 8:00 a.m. eastern time.